Clinical Trial Update: Platelet-Rich and Concentrated Platelet-Poor Plasma to Reduce Air Leak Post-Lobectomy: A Randomized Controlled Trial [NA]

View source ↗

Summary

A randomized controlled trial assessed autologous platelet-rich plasma and concentrated platelet-poor plasma to reduce air leaks after lobectomy in lung cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Autologous Platelet-Rich Plasma (PRP) (platelet-rich plasma)
• Concentrated platelet-poor plasma (platelet-poor plasma)

Snippet

Sponsor: Zimmer Biomet | Conditions: Lung Cancer | NA | Status: COMPLETED